Galenica (SWX:GALE) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

GALE Aktienübersicht

Die Galenica AG ist als Gesundheitsdienstleisterin in der Schweiz und international tätig.

GALE fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	5/6
Financial Health	6/6
Dividends	3/6

Belohnungen

38.4% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 5.22% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 5.3%

Risikoanalyse

Unbeständige Dividendenentwicklung

Galenica AG Wettbewerber

Ypsomed Holding

SWX:YPSN

CHF5.3b

Medacta Group

SWX:MOVE

CHF2.5b

China National Medicines

SHSE:600511

CN¥26.0b

Sonova Holding

SWX:SOON

CHF17.2b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Galenica
Historical stock prices
Current Share Price	CHF73.00
52 Week High	CHF78.15
52 Week Low	CHF65.10
Beta	0.19
1 Month Change	3.47%
3 Month Change	-3.88%
1 Year Change	2.67%
3 Year Change	14.33%
5 Year Change	50.14%
Change since IPO	69.77%

Aktuelle Nachrichten und Updates

Recent updates

Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected

Apr 25

We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right

Apr 04

Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement

Mar 29

Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now

Jan 22

Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?

Jan 04

Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes

Oct 26

Is Galenica (VTX:GALE) Using Too Much Debt?

Oct 11

Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?

Sep 26

These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well

Jun 20

Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return

Apr 17

We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt

Mar 12

Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes

Jan 08

These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well

Nov 28

The Returns At Galenica (VTX:GALE) Aren't Growing

Sep 20

Is Galenica (VTX:GALE) A Risky Investment?

Aug 30

Return Trends At Galenica (VTX:GALE) Aren't Appealing

Jun 15

Galenica (VTX:GALE) Could Easily Take On More Debt

Apr 06

Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward

Feb 15

Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?

Jan 02

Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?

Nov 30

Returns At Galenica (VTX:GALE) Appear To Be Weighed Down

Oct 24

With EPS Growth And More, Galenica (VTX:GALE) Is Interesting

Sep 25

Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly

Aug 24

Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward

Jul 24

If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late

Jun 12

Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)

Apr 07

Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly

Mar 25

Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Mar 11

Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?

Feb 27

Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?

Jan 31

Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain

Jan 13

Is Galenica (VTX:GALE) Likely To Turn Things Around?

Dec 25

Is Galenica (VTX:GALE) A Risky Investment?

Dec 09

Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?

Nov 24

Aktionärsrenditen

	GALE	CH Healthcare	CH Markt
7D	2.7%	0.8%	3.6%
1Y	2.7%	2.4%	7.5%

Rendite im Vergleich zur Industrie: GALE wie die Branche Swiss Healthcare, die im vergangenen Jahr eine Rendite von 2.4 erzielte.

Rendite vs. Markt: GALE übertraf den Markt Swiss, der im vergangenen Jahr eine Rendite von 1.9 erzielte.

Preisvolatilität

Is GALE's price volatile compared to industry and market?
GALE volatility
GALE Average Weekly Movement	2.0%
Healthcare Industry Average Movement	4.9%
Market Average Movement	3.4%
10% most volatile stocks in CH Market	6.3%
10% least volatile stocks in CH Market	1.9%

Stabiler Aktienkurs: GALE hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: GALEDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1927	6,181	Marc Werner	www.galenica.com

Die Galenica AG ist ein in der Schweiz und international tätiges Dienstleistungsunternehmen im Gesundheitswesen. Sie ist in zwei Segmenten tätig: Products & Care sowie Logistics & IT. Das Segment Products & Care betreibt Apotheken und Partnerapotheken unter den Marken Amavita, Sun Store und Coop Vitality.

Galenica AG's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Galenica im Vergleich zum Marktanteil des Unternehmens?
GALE grundlegende Statistiken
Marktanteil	CHF3.64b
Gewinn(TTM)	CHF164.92m
Umsatz(TTM)	CHF3.76b

22.1x

Kurs-Gewinn-Verhältnis

1.0x

Kurs-Umsatz-Verhältnis

Ist GALE zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
GALE Gewinn- und Verlustrechnung (TTM)
Einnahmen	CHF3.76b
Kosten der Einnahmen	CHF3.29b
Bruttogewinn	CHF461.34m
Sonstige Ausgaben	CHF296.43m
Umsatz	CHF164.92m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

Aug 06, 2024

Gewinn per Aktie (EPS)	3.31
Bruttomarge	12.28%
Nettogewinnspanne	4.39%
Schulden/Eigenkapital-Verhältnis	33.2%

Wie hat sich GALE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.0%

Aktuelle Dividendenrendite

66%

Ausschüttungsquote

GALE Aktienübersicht

Belohnungen

Risikoanalyse

Galenica AG Wettbewerber

SWX:YPSN

CHF5.3b

SWX:MOVE

CHF2.5b

SHSE:600511

CN¥26.0b

SWX:SOON

CHF17.2b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected

Upcoming dividend of CHF2.20 per share

We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right

Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement

Full year 2023 earnings: EPS exceeds analyst expectations

Galenica AG to Report Fiscal Year 2024 Results on Mar 11, 2025

Recent updates

Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected

Upcoming dividend of CHF2.20 per share

We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right

Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement

Full year 2023 earnings: EPS exceeds analyst expectations

Galenica AG to Report Fiscal Year 2024 Results on Mar 11, 2025

Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now

Galenica AG to Report First Half, 2024 Results on Aug 06, 2024

Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?

Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes

Is Galenica (VTX:GALE) Using Too Much Debt?

Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?

First half 2023 earnings released: EPS: CHF1.49 (vs CHF1.59 in 1H 2022)

New minor risk - Financial position

These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well

Galenica AG (SWX:GALE) acquired AD Swiss Net AG.

Galenica AG to Report Fiscal Year 2023 Final Results on Mar 12, 2024

Upcoming dividend of CHF2.20 per share at 2.7% yield

Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return

We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt

Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes

These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well

Bruno sauter acquired Careproduct AG on Galenica AG (SWX:GALE).

The Returns At Galenica (VTX:GALE) Aren't Growing

Is Galenica (VTX:GALE) A Risky Investment?

First half 2022 earnings released

Galenica AG to Report Q2, 2023 Results on Aug 08, 2023

Galenica AG (SWX:GALE) acquired Aquantic Ltd.

Return Trends At Galenica (VTX:GALE) Aren't Appealing

Galenica AG (SWX:GALE) acquired an unknown stake in Well Gesundheit AG.

Galenica AG, Annual General Meeting, May 03, 2023

Upcoming dividend of CHF2.10 per share

Galenica (VTX:GALE) Could Easily Take On More Debt

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward

Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?

Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?

Returns At Galenica (VTX:GALE) Appear To Be Weighed Down

With EPS Growth And More, Galenica (VTX:GALE) Is Interesting

Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly

First half 2021 earnings released: EPS CHF1.60 (vs CHF1.34 in 1H 2020)

Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward

If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late

Upcoming dividend of CHF1.80 per share

Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)

Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly

Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Full year 2020 earnings released: EPS CHF3.48 (vs CHF2.54 in FY 2019)

Revenue and earnings beat expectations

New 90-day low: CHF57.90

Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?

Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?

Galenica AG to Report First Half, 2021 Results on Aug 03, 2021

Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain

Is Galenica (VTX:GALE) Likely To Turn Things Around?

Biofrontera Pharma GmbH Enters into License and Supply Agreement with Galenica AB for the Marketing of Ameluz in Scandinavia

Is Galenica (VTX:GALE) A Risky Investment?

Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?

New 90-day low: CHF60.95

Erträge & Einnahmen